The NIH funded academic institutions to design programs for professional development, but because doctoral training is lengthy and requires focused attention on research, some researchers feared students participating in additional training...
13-Jul-2021 12:00 PM EDT Add to Favorites
Migraine is one of the largest causes of disability in the world. Existing treatments are often not enough to offer full relief for patients. A new study published in The BMJ demonstrates an additional option patients can use in their effort to...
2-Jul-2021 7:05 AM EDT Add to Favorites
UNC School of Medicine scientists have demonstrated that variants in the SPTBN1 gene can alter neuronal architecture, dramatically affecting their function and leading to a rare, newly defined neurodevelopmental syndrome in children.
1-Jul-2021 8:00 AM EDT Add to Favorites
UNC-Chapel Hill scientists investigated blood samples from children enrolled in a dengue vaccine trial to identify the specific kinds of antibody responses that correlate with protection against dengue virus disease.
25-Jun-2021 10:00 AM EDT Add to Favorites
For the first, time UNC School of Medicine scientist Katie Baldwin, PhD, and colleagues revealed a central role of the glial protein hepaCAM in building the brain and affecting brain function early in life.
25-Jun-2021 8:05 AM EDT Add to Favorites
Diabetes is one of the comorbidities most strongly associated with severe COVID-19 in the US, and data from early in the pandemic suggested individuals with type 2 diabetes faced twice the risk of death from COVID-19 and a greater risk of requiring...
17-Jun-2021 4:15 PM EDT Add to Favorites
Scientists created a potentially powerful new strategy for treating cystic fibrosis and potentially other diseases; it involves small, nucleic acid molecules called oligonucleotides that can correct some of the gene defects that underlie CF but are...
16-Jun-2021 8:05 AM EDT Add to Favorites
The Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical research. There were no adverse effects.
16-Jun-2021 8:00 AM EDT Add to Favorites
See All News
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center experts are available to provide expert commentary and feedback on research presented at the AACR Annual Meeting 2018.
13-Apr-2018 10:05 AM EDT
Dr. Thomas Egan of the University of North Carolina School of Medicine says that a recent change in donor lung allocation policy was long overdue. However, because the change happened over the Thanksgiving holiday weekend in response to litigation,...
16-Jan-2018 10:05 AM EST
UNC Health Care and the UNC School of Medicine have launched a tool for media to request interviews with experts and researchers at the forefront of the global Zika research initiative.
12-Jul-2016 9:05 AM EDT
20-Mar-2014 3:00 PM EDT
Experts Available to Discuss NEJM Editorial on Use of PARP Inhibitors in Triple-Negative Breast Cancer
In the editorial, the UNC researchers explain the excitement about this new class of drugs and the importance of this trial. They also highlight the reasons that caution as well as enthusiasm is warranted.
3-Jan-2011 2:50 PM EST
Dr. Darren DeWalt, author of a JAMA editorial being released early online this week, is available for media interviews.
29-Nov-2010 11:45 AM EST
UNC expert available to discuss latest development in search for AIDS vaccine.
24-Sep-2009 12:40 PM EDT
UNC brain surgeon Anand Germanwala, M.D. and ENT surgeon Adam Zanation, M.D., collaborated to develop through-the-nose approach to repair a patient's ruptured brain aneurysm.
26-Aug-2009 9:00 AM EDT